-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Petros Pharmaceuticals, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2020 to Q3 2024.
- Petros Pharmaceuticals, Inc. Depreciation, Depletion and Amortization for the quarter ending September 30, 2024 was $739K, a 10.6% decline year-over-year.
- Petros Pharmaceuticals, Inc. Depreciation, Depletion and Amortization for the twelve months ending September 30, 2024 was $2.98M, a 12.3% decline year-over-year.
- Petros Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2023 was $3.28M, a 41.4% decline from 2022.
- Petros Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2022 was $5.6M, a 18.6% decline from 2021.
- Petros Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2021 was $6.88M, a 3.27% increase from 2020.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)